AKT

You have access
Virtual Screening of 1,4-Naphthoquinone Derivatives for Inhibition of a Key Cancer Signaling Protein, AKT1 Kinase
MOHD REHAN and MAGED MOSTAFA

Anticancer Research July 2019, 39 (7) 3823-3833; DOI: https://doi.org/10.21873/anticanres.13532
You have access
Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial–Mesenchymal Transition of Thyroid Carcinoma Cells
SI HYOUNG KIM, JUN GOO KANG, CHUL SIK KIM, SUNG-HEE IHM, MOON GI CHOI and SEONG JIN LEE

Anticancer Research November 2018, 38 (11) 6339-6352; DOI: https://doi.org/10.21873/anticanres.12992
You have access
Evaluation of Therapeutic Potential of Phenoxodiol, a Novel Isoflavone Analog, in Renal Cancer Cells
MAKOTO ISONO, AKINORI SATO, TAKAKO ASANO, KAZUKI OKUBO and TOMOHIKO ASANO

Anticancer Research October 2018, 38 (10) 5709-5716; DOI: https://doi.org/10.21873/anticanres.12908
You have access
Enigma Plays Roles in Survival of Thyroid Carcinoma Cells through PI3K/AKT Signaling and Survivin
YOON JUNG KIM, HYO-JEONG HWANG, JUN GOO KANG, CHUL SIK KIM, SUNG-HEE IHM, MOON GI CHOI and SEONG JIN LEE

Anticancer Research June 2018, 38 (6) 3515-3525; DOI: https://doi.org/10.21873/anticanres.12623
You have access
Amentoflavone Enhances the Therapeutic Efficacy of Sorafenib by Inhibiting Anti-apoptotic Potential and Potentiating Apoptosis in Hepatocellular Carcinoma In Vivo
JAI-JEN TSAI, FEI-TING HSU, PO-JUNG PAN, CHIA-WEN CHEN and YU-CHENG KUO

Anticancer Research April 2018, 38 (4) 2119-2125;
You have access
Batatasin III Inhibits Migration of Human Lung Cancer Cells by Suppressing Epithelial to Mesenchymal Transition and FAK-AKT Signals
TATCHAKORN PINKHIEN, NAREERAT PETPIROON, BOONCHOO SRITULARAK and PITHI CHANVORACHOTE

Anticancer Research November 2017, 37 (11) 6281-6289;
You have access
Cycloartobiloxanthone Inhibits Migration and Invasion of Lung Cancer Cells
SUCHARAT TUNGSUKRUTHAI, BOONCHOO SRITULARAK and PITHI CHANVORACHOTE

Anticancer Research November 2017, 37 (11) 6311-6319;
You have access
Design and Synthesis of Novel Anti-metastatic Hypoxic Cytotoxin TX-2137 Targeting AKT Kinase
IKKYU SHIBA, RISA KOUZAKI, HISATSUGU YAMADA, YOSHIO ENDO, TAKAHISA TAKINO, HIROSHI SATO, KEIKO KITAZATO, TERUYOSHI KAGEJI, SHINJI NAGAHIRO and YOSHIHIRO UTO

Anticancer Research July 2017, 37 (7) 3877-3883;
You have access
The Anticancer Effects of Novel α-Bisabolol Derivatives Against Pancreatic Cancer
YOSHIHIKO MURATA, TOSHIO KOKURYO, YUKIHIRO YOKOYAMA, JUNPEI YAMAGUCHI, TOMOHIRO MIWA, MASATOSHI SHIBUYA, YOSHIHIKO YAMAMOTO and MASATO NAGINO

Anticancer Research February 2017, 37 (2) 589-598;
You have access
ID1 Controls Aggressiveness of Salivary Gland Cancer Cells via Crosstalk of IGF and AKT Pathways
TOMOKI SUMIDA, YU KAMATA, YOSUKE KOBAYASHI, AKIKO ISHIKAWA and YOSHIHIDE MORI

Anticancer Research August 2016, 36 (8) 3865-3870;

Main menu

User menu

Search

AKT

Pages